# A Study of SYH2069 Injection in Healthy Participants

> **NCT07736391** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **CSPC Ouyi Pharmaceutical Co., Ltd.** · enrollment: 104 (actual)

## Conditions studied

- Overweight or Obesity
- Diabetes

## Interventions

- **DRUG:** SYH2069 Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07736391
- **Lead sponsor:** CSPC Ouyi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736391, "A Study of SYH2069 Injection in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*